Alphatec Holdings (ATEC) R&D In Process (2010 - 2015)
Alphatec Holdings recorded quarterly R&D In Process of $274000.0 in Q3 2015, down 48.01% quarter-over-quarter from $527000.0 in Q3 2014, and down 48.01% year-over-year from $527000.0 in Q3 2014.
Alphatec Holdings' R&D In Process history runs 3 years deep, the most recent figure standing at $274000.0 for Q3 2015.
- In Q3 2015, R&D In Process fell 48.01% year-over-year to $274000.0; the TTM figure through Sep 2016 stood at $274000.0 (down 65.79% YoY), while the FY2015 annual figure was $274000.0, down 48.01% from the prior year.
- R&D In Process came in at $274000.0 for Q3 2015 at Alphatec Holdings, down from $527000.0 in the prior quarter.
- In the past five years, R&D In Process ranged from a high of $527000.0 in Q3 2014 to a low of $274000.0 in Q3 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D In Process (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Alphatec Holdings | 1.15 Bn | 1.01 Bn | 136.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 274,000.00 |
| Sep 30, 2014 | 527,000.00 |
| Sep 30, 2010 | 2.43 Mn |
| Jun 30, 2010 | 92,000.00 |